122 related articles for article (PubMed ID: 33326137)
1. Hospitalizations in long-term survivors of childhood AML treated with allogeneic HCT-An Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.
Wilhelmsson M; Jahnukainen K; Winiarski J; Abrahamsson J; Bautz A; Gudmundsdottir T; Madanat-Harjuoja LM; Holmqvist AS; Winther JF; Hasle H;
Am J Hematol; 2021 Mar; 96(3):E74-E77. PubMed ID: 33326137
[No Abstract] [Full Text] [Related]
2. Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.
Kenborg L; Winther JF; Linnet KM; Krøyer A; Albieri V; Holmqvist AS; Tryggvadottir L; Madanat-Harjuoja LM; Stovall M; Hasle H; Olsen JH;
Neuro Oncol; 2019 Jan; 21(1):125-136. PubMed ID: 29850875
[TBL] [Abstract][Full Text] [Related]
3. Somatic late effects in 5-year survivors of neuroblastoma: a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia study.
Norsker FN; Rechnitzer C; Cederkvist L; Holmqvist AS; Tryggvadottir L; Madanat-Harjuoja LM; Øra I; Thorarinsdottir HK; Vettenranta K; Bautz A; Schrøder H; Hasle H; Winther JF
Int J Cancer; 2018 Dec; 143(12):3083-3096. PubMed ID: 29926896
[TBL] [Abstract][Full Text] [Related]
4. Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis.
Konuma T; Harada K; Yamasaki S; Mizuno S; Uchida N; Takahashi S; Onizuka M; Nakamae H; Hidaka M; Fukuda T; Ohashi K; Kohno A; Matsushita A; Kanamori H; Ashida T; Kanda J; Atsuta Y; Yano S;
Am J Hematol; 2019 Jan; 94(1):103-110. PubMed ID: 30370944
[TBL] [Abstract][Full Text] [Related]
5. Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study.
de Fine Licht S; Winther JF; Gudmundsdottir T; Holmqvist AS; Bonnesen TG; Asdahl PH; Tryggvadottir L; Anderson H; Wesenberg F; Malila N; Holm K; Hasle H; Olsen JH;
Lancet; 2014 Jun; 383(9933):1981-9. PubMed ID: 24556022
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
[TBL] [Abstract][Full Text] [Related]
7. Hospital admission for neurologic disorders among 5-year survivors of noncentral nervous system tumors in childhood: A cohort study within the Adult Life after Childhood Cancer in Scandinavia study.
Kenborg L; Linnet KM; de Fine Licht S; Bautz A; Holmqvist AS; Tryggvadottir L; Madanat-Harjuoja LM; Stovall M; Heilmann C; Albieri V; Hasle H; Winther JF;
Int J Cancer; 2020 Feb; 146(3):819-828. PubMed ID: 30980681
[TBL] [Abstract][Full Text] [Related]
8. Neurologic disorders in long-term survivors of neuroblastoma - a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) research program.
Norsker FN; Rechnitzer C; Andersen EW; Linnet KM; Kenborg L; Holmqvist AS; Tryggvadottir L; Madanat-Harjuoja LM; Øra I; Thorarinsdottir HK; Vettenranta K; Bautz A; Schrøder H; Hasle H; Winther JF
Acta Oncol; 2020 Feb; 59(2):134-140. PubMed ID: 31591921
[No Abstract] [Full Text] [Related]
9. Hyperthyroidism as a late effect in childhood cancer survivors - an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.
Clausen CT; Hasle H; Holmqvist AS; Madanat-Harjuoja L; Tryggvadottir L; Wesenberg F; Bautz A; Winther JF; de Fine Licht S
Acta Oncol; 2019 Feb; 58(2):227-231. PubMed ID: 30585514
[TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Baron F; Labopin M; Peniket A; Jindra P; Afanasyev B; Sanz MA; Deconinck E; Nagler A; Mohty M
Cancer; 2015 Apr; 121(7):1048-55. PubMed ID: 25424330
[TBL] [Abstract][Full Text] [Related]
11. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
[TBL] [Abstract][Full Text] [Related]
12. Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.
Michelis FV; Messner HA; Atenafu EG; McGillis L; Lambie A; Uhm J; Alam N; Seftel MD; Gupta V; Kuruvilla J; Lipton JH; Kim DD
Bone Marrow Transplant; 2015 Nov; 50(11):1405-10. PubMed ID: 26168067
[TBL] [Abstract][Full Text] [Related]
13. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
Oran B; Giralt S; Couriel D; Hosing C; Shpall EJ; de Meis E; Khouri IF; Qazilbash M; Anderlini P; Kebriaei P; Popat U; Carrasco-Yalan A; Champlin RE; de Lima M
Leukemia; 2007 Dec; 21(12):2540-4. PubMed ID: 17611563
[No Abstract] [Full Text] [Related]
14. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Beelen D; Ciceri F; Volin L; Shimoni A; Foá R; Milpied N; Peccatori J; Polge E; Mailhol A; Mohty M; Savani BN
Cancer; 2017 Jul; 123(14):2671-2679. PubMed ID: 28329410
[TBL] [Abstract][Full Text] [Related]
15. Long-term inpatient disease burden in the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors.
de Fine Licht S; Rugbjerg K; Gudmundsdottir T; Bonnesen TG; Asdahl PH; Holmqvist AS; Madanat-Harjuoja L; Tryggvadottir L; Wesenberg F; Hasle H; Winther JF; Olsen JH;
PLoS Med; 2017 May; 14(5):e1002296. PubMed ID: 28486495
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
[TBL] [Abstract][Full Text] [Related]
17. Liver diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): A population-based cohort study of 32,839 one-year survivors.
Bonnesen TG; Winther JF; Andersen KK; Asdahl PH; de Fine Licht S; Gudmundsdottir T; Sällfors Holmqvist A; Madanat-Harjuoja LM; Tryggvadottir L; Wesenberg F; Heilmann C; Olsen JH; Hasle H;
Int J Cancer; 2018 Feb; 142(4):702-708. PubMed ID: 29023764
[TBL] [Abstract][Full Text] [Related]
18. Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission.
Lee YJ; Baek DW; Ahn JS; Ahn SY; Jung SH; Yang DH; Lee JJ; Kim HJ; Ham JY; Suh JS; Sohn SK; Moon JH
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e529-e535. PubMed ID: 30268640
[TBL] [Abstract][Full Text] [Related]
19. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state.
Rashidi A; Ali AM; Vij KR; Shanley R; Romee R; Cooley SA; Westervelt P; DiPersio JF; Miller JS; Weisdorf DJ; Ustun C
Am J Hematol; 2017 Sep; 92(9):E549-E552. PubMed ID: 28568483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
